Comprehensive Guide to Whistleblower Laws: the False Claims Act
Understanding the False Claims Act: A Strategic Overview
The False Claims Act (FCA) - and its qui tam provision - is one of the federal government’s most potent (and effective) tools for protecting public funds from fraud and abuse.
Originally enacted during the Civil War, the FCA has evolved significantly over time. Today, it directly impacts a broad range of industries—including healthcare, defense contracting, and financial services—and has implications for all entities that receive or handle government funds. Whether you are a whistleblower or running a business that receives federal funds, understanding what the FCA is and how it operates is a critical first step.
What Is the False Claims Act?
At bottom, the FCA imposes liability on individuals and organizations that knowingly submit false or fraudulent claims for payment to the government. This can encompass a wide range of conduct as further described below, as examples: billing Medicare or Medicaid for services not rendered, charging the Department of Defense for substandard materials, or misrepresenting qualifications when bidding for federal contracts. The Act is extremely broad, ensuring that it can address both straightforward and highly complex schemes.
The False Claims Act (FCA) is codified at 31 U.S.C. §§ 3729–3733. While it contains multiple provisions, the core language to know is found in 31 U.S.C. § 3729(a), which establishes liability for submitting false or fraudulent claims to the federal Government. Key elements include:
Liability Provision (31 U.S.C. § 3729(a)):
This section states that any person who does any of the following can be liable under the FCA:
Knowingly presents (or causes to be presented) a false or fraudulent claim for payment or approval to the U.S. government.
Knowingly makes, uses, or causes to be made or used a false record or statement material to a false or fraudulent claim.
Conspires to commit a violation of the FCA’s prohibitions.
Falsely certifies that certain property or services meet government specifications, among other enumerated wrongful acts.
The term “knowingly” is broadly defined to include actual knowledge, deliberate ignorance, or reckless disregard of the truth or falsity of the information. This means a person or entity does not have to intend to defraud the government in a traditional sense; careless or willfully blind mistakes can also lead to liability.
Damages and Penalties:
There are significant penalties for violating the FCA. If found liable, a defendant can be required to pay up to three times the government’s damages (treble damages) plus substantial civil penalties for each false claim. These penalties are adjusted periodically for inflation and serve as a strong deterrent.
Key Takeaways About the FCA:
Submitting or causing the submission of false claims for government funds is prohibited.
“Knowledge” encompasses more than intentional fraud; it also includes reckless or willfully blind conduct.
Private individuals can initiate litigation on behalf of the government through qui tam provisions.
Penalties are steep, often involving treble damages and sizable fines.
Who Is Covered and What Counts as a “False Claim”?
Entities and Individuals Covered by the FCA:
The reach of the False Claims Act extends well beyond large corporations. While major healthcare providers, defense contractors, and financial institutions frequently find themselves under FCA scrutiny, the law also applies to smaller companies, non-profit organizations, and individual professionals who interact with federal funds. In addition, personal liability is not limited to corporate leaders alone—managers, employees, or even outside consultants who knowingly participate in or facilitate the submission of a false claim can be held accountable. In essence, any party that knowingly causes the government to pay out funds under false pretenses risks liability under the FCA.
Types of Fraudulent Activity:
A “false claim” encompasses a wide array of conduct designed to secure an unjustified financial benefit from the government. Common examples include:
Overbilling Healthcare Programs: For instance, charging Medicare or Medicaid for medical procedures that were never performed, or inflating the cost of services provided to patients. Read more.
Misrepresenting Goods or Services: Providing substandard equipment or materials—such as faulty military parts to the Department of Defense—while certifying that they meet contract specifications. Read more.
Falsifying Research or Grant Applications: Fabricating data, inflating research costs, or misrepresenting qualifications in grant proposals submitted to federal agencies. Read more.
Improper Use of Federal Funds: Diverting government funds for unauthorized purposes or failing to deliver promised services while still billing for them. Read more.
In practice, any scheme that induces the government to pay out money it would not otherwise have expended—or to forgo funds it would have otherwise collected—can constitute a false claim. The broad scope of the FCA ensures that it can adapt to evolving business models, technology, and funding mechanisms, making comprehensive compliance measures imperative for organizations of all types and sizes.
Record-Setting False Claims Act Cases
Over the years, the False Claims Act has been at the center of numerous high-profile (and lucrative) cases, resulting in some of the largest recoveries in the history of U.S. law enforcement against fraud.
Below are a few notable examples:
GlaxoSmithKline (GSK) – $3 Billion Settlement (2012): In one of the largest healthcare fraud settlements on record, GSK agreed to pay $3 billion to resolve criminal and civil charges involving the unlawful promotion of certain prescription drugs, failure to report safety data, and false price reporting practices. This case underscored the government’s commitment to pursuing pharmaceutical companies that misrepresent drug efficacy or safety to bolster sales.
Pfizer – $2.3 Billion Settlement (2009): Pfizer’s $2.3 billion settlement remains one of the largest FCA resolutions in the healthcare sector. The company paid this amount to settle claims that it promoted several drugs for uses not approved by the Food and Drug Administration (FDA) and made false claims to government health programs, ultimately driving up taxpayer costs.
Johnson & Johnson – $2.2 Billion Settlement (2013): Johnson & Johnson resolved FCA allegations related to its marketing of certain prescription drugs for unapproved uses, including use on vulnerable populations such as children and individuals with disabilities. This case highlighted the FCA’s role in holding pharmaceutical manufacturers accountable for sales and marketing practices that lead to improper billing of government healthcare programs.
Boeing – $615 Million Settlement (2006): The aerospace and defense giant agreed to pay $615 million to settle multiple FCA cases alleging improper use of competitors’ information to win government contracts. This high-profile settlement signaled the FCA’s influence in ensuring fair contracting practices and deterring misconduct in the defense industry.
HCA – $1.7 Billion Settlement (2000): Prior to some of the major pharmaceutical cases, HCA’s agreement to pay $1.7 billion was, at the time, the largest healthcare fraud settlement in U.S. history. The claims included illegal billing practices, false cost reports, and inflated charges to Medicare and Medicaid, reflecting the FCA’s longstanding importance in protecting government-funded healthcare programs.
University of Phoenix – $67.5 Million Settlement (2009): The University of Phoenix paid $67.5 million to resolve allegations that it violated the FCA by misrepresenting its compliance with federal student aid rules. This case highlighted the FCA’s ability to reach beyond healthcare and defense into the for-profit education sector, ensuring that institutions receiving federal funds adhere to applicable standards.
Recent “Unique” Uses of the FCA
While the False Claims Act (FCA) is best known for its central role in combating healthcare and defense contracting fraud, its flexibility has led to a range of less traditional—and often quite innovative—applications. Over time, federal enforcement priorities and evolving industry practices have prompted the government and whistleblowers to use the FCA in new contexts. We have seen an uptick in healthcare-related cases, particularly involving alleged Medicare and Medicaid fraud. There has also been a focus on COVID-19 relief fraud, reflecting the government’s attention to emergency funding programs. Additionally, enforcement authorities continue to scrutinize the defense and technology sectors, where government dollars often fuel innovation and large-scale projects.
Here are a few examples:
Cybersecurity and Data Protection Compliance: As government agencies increasingly rely on private contractors to handle sensitive information, cybersecurity standards have become more stringent. Contractors who fail to meet these standards—but certify compliance anyway—could find themselves facing FCA liability. This approach encourages improved data security and ensures the government receives the protections it pays for.
Research Fraud and Academic Misconduct: Universities, research institutions, and private companies receiving federal grants have faced FCA actions for falsifying research data, misrepresenting qualifications, or inflating costs in their applications. By using the FCA to combat research fraud, enforcement authorities help maintain the integrity of federally funded scientific and academic programs.
For-Profit Education and Student Aid: For-profit colleges that misrepresent graduation rates, job placement statistics, or accreditation to qualify for federal student aid programs have been subject to FCA lawsuits. This ensures that federal funds devoted to education serve genuine academic and professional development rather than deceptive practices.
COVID-19 Relief and Emergency Funding: During the COVID-19 pandemic, substantial federal relief funds flowed to businesses, healthcare providers, and non-profit organizations. The FCA has provided a legal pathway to address misuse of these relief funds—such as falsely claiming eligibility for Paycheck Protection Program loans or inflating the need for emergency medical supplies.
Environmental and Energy Sector Compliance: While less common than in healthcare or defense, the FCA has been invoked in cases where companies misrepresent compliance with environmental regulations tied to federal funding or contracts. In this way, the FCA can be leveraged to uphold environmental standards and ensure that taxpayer dollars support sustainable and lawful projects.
These unique applications of the FCA demonstrate its adaptability. By using the FCA to address emerging areas of misconduct, the government and whistleblowers help ensure that evolving business practices, technologies, and funding mechanisms remain subject to meaningful oversight and accountability.
Key FCA Provision and Enforcement Mechanism: The Qui Tam Provision
One of the FCA’s defining features is its qui tam provision, which allows private individuals—often employees or other insiders—to file lawsuits on behalf of the government. These whistleblowers, technically referred to as “relators,” can share in the government’s recovery if the case succeeds. This mechanism encourages those with firsthand knowledge of wrongdoing to come forward, strengthening enforcement by leveraging insights that would otherwise remain hidden.
The U.S. Department of Justice (DOJ) is responsible for reviewing qui tam complaints and deciding whether to intervene. Where the DOJ intervenes (typically after a case is filed under seal), it brings the government’s investigative and prosecutorial resources to bear, often resulting in substantial settlements or judgments. Even in cases where the government declines to intervene, whistleblowers can proceed on their own, supported by their legal counsel.
From an individual whistleblower standpoint, the FCA (and its qui tam provisions) offers both protections and opportunities. Whistleblowers who come forward with credible information about fraud are generally shielded from retaliation by their employers. In addition, if their case leads to a successful recovery, the whistleblower may receive an insignificant percentage of the funds recovered.
If you are considering coming forward with information about government fraud, understanding how to file a False Claims Act whistleblower lawsuit is critical. Initiating a qui tam action under the FCA involves strict procedural requirements and deadlines. Consulting an attorney at Dynamis LLP who regularly assists relators with reporting government fraud under the False Claims Act can ensure you meet these requirements and maximize the potential success of your claim. Whistleblowers, also known as relators, play a vital role in protecting taxpayer funds, and if the government intervenes and recovers funds, the relator may be entitled to a share of the recovery.
Law Firms Such as Dynamis LLP Can Help
A law firm experienced in False Claims Act (FCA) matters, such as Dynamis LLP, can add value and guidance at every stage of the process. For individuals who discover and wish to report fraud against the government, Dynamis LLP can help:
Assess the Merits of the Case: Determine whether the facts meet FCA requirements and how likely it is the government will intervene.
Guide Through the Filing Process: Help prepare and file a qui tam complaint under seal, manage communication with the Department of Justice prosecutors, and navigate procedural complexities.
Protect Whistleblower Rights: Advise on anti-retaliation protections, negotiate potential settlements, and work to secure a share of the government’s recovery if the case succeeds.
In short, Dynamis can help clients navigate a complex and evolving legal landscape. By providing informed advice, protecting clients’ interests, and working toward the most favorable outcome—whether through compliance initiatives, preemptive risk management, negotiation, or litigation—a skilled legal team, such as the one at Dynamis, can be an indispensable ally.
Take the First Step Towards Becoming a Whistleblower
If you are considering exposing fraud or misconduct, protect your rights by contacting attorneys at Dynamis LLP. Our experienced whistleblower attorneys are here to guide you through every step. Contact whistleblowers@dynamisllp.com today.
Further Resources on Whistleblower Law and Filing a Claim
-
The False Claims Act is a federal law that allows individuals to file lawsuits on behalf of the government against those who commit fraud involving government funds or contracts. Whistleblowers, known as relators, can receive a portion of any recovered damages as a reward for exposing wrongdoing.
-
The SEC Whistleblower Program, established under the Dodd-Frank Act, incentivizes individuals to report securities law violations by offering monetary awards ranging from 10% to 30% of sanctions collected in successful enforcement actions exceeding $1 million. Whistleblowers can submit tips anonymously and are protected against employer retaliation, encouraging the reporting of misconduct.
-
Whistleblowers can, at times, be subject to significant retaliation. It is critical to retain counsel to determine how to deal with retaliation.
-
Whistleblowers can often obtain significant monetary rewards for reporting misconduct, waste, or fraud.
-
There are numerous different laws that cover whistleblowing. It is critical to understand them before deciding whether and where to file an action.
-
Federal court in Boston is one of the nation’s best (and most active) forums for bringing a whistleblower claim.
-
South Florida is a hotbed for fraud, and Florida federal courts are an excellent venue for filing whistleblower suits.
-
Home to the nation’s largest financial institutions, federal courts in New York are an ideal venue for filing whistleblower suits.
Dynamis attorneys have significant experience in evaluating and prosecuting whistleblower claims, both as former federal prosecutors and as defense attorneys. Do not hesitate to reach out today to discuss your case with Dynamis. Contact Eric Rosen or Michael Homer.